ESR1 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) is characterized for being negative in the expression of human epidermal growth factor receptor 2 (HER2), estrogen receptor (ER), and progesterone receptor (PR), and accounts for ~15% of invasive breast cancers (1, 2).